Skip to main content
Atrás
Watch Compare

CollPlant Biotechnologies Ltd

Calidad de datos: 100%
CLGN
Nasdaq Manufacturing Measuring & Analyzing Instruments
$0.37
▲ $0.03 (9.14%)
Cap. Mercado: 5.34 M
Precio
$0.37
Cap. Mercado
5.34 M
Rango del Día
$0.34 — $0.39
Rango de 52 Semanas
$0.32 — $4.98
Volumen
62,750
Apertura $0.34
Promedio 50D / 200D
$0.84
55.97% below
Promedio 50D / 200D
$1.79
79.33% below

Quick Summary

Puntos Clave

Revenue declined -37.60% annually over 5 years
Negative free cash flow of -9.45 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 397.99%
Capital efficient — spends only 1.18% of revenue on capex

Crecimiento

Revenue Growth (5Y)
-37.60%
Below sector avg (9.35%)
Revenue (1Y)360.39%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
-40.48%
Above sector avg (-51.02%)
ROIC-29.21%
Net Margin-484.56%
Op. Margin-484.31%

Seguridad

Debt / Equity
N/A
Current Ratio6.27
Interest CoverageN/A

Valoración

PE (TTM)
-0.46
Above sector avg (-1.98)
P/B Ratio0.26
EV/EBITDAN/A
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (44 pares)
Métrica Acción Mediana del Sector
P/E -0.5 -2.0
P/B 0.3 5.1
ROE % -40.5 -51.0
Net Margin % -484.6 -150.2
Rev Growth 5Y % -37.6 9.3
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) 360.39% Revenue Growth (3Y) -53.49%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -37.60% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 2.37 M Net Income (TTM) -11.49 M
ROE -40.48% ROA -33.72%
Gross Margin 64.78% Operating Margin -484.31%
Net Margin -484.56% Free Cash Flow (TTM) -9.45 M
ROIC -29.21% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 6.27
Interest Coverage N/A Asset Turnover 0.07
Working Capital 17.09 M Tangible Book Value 20.57 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.46 Forward P/E N/A
P/B Ratio 0.26 P/S Ratio 2.25
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -177.07%
Market Cap 5.34 M Enterprise Value -13.58 M
Per Share
EPS (Diluted TTM) -0.94 Revenue / Share 0.16
FCF / Share -0.66 OCF / Share -0.65
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 1.18% FCF Conversion 82.23%
SBC-Adj. FCF N/A Growth Momentum 397.99

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 2.37 M 515,000.0 10.96 M 299,000.0 15.64 M
Net Income -11.49 M -16.61 M -7.02 M -16.93 M 237,000.0
EPS (Diluted) -0.94 -1.45 -0.62 -1.53 0.02
Gross Profit 1.54 M -1.11 M 8.97 M -101,000.0 13.64 M
Operating Income -11.48 M -17.25 M -7.51 M -17.10 M 65,000.0
EBITDA — — — — —
R&D Expenses 8.19 M 10.52 M 10.48 M 10.26 M 7.63 M
SG&A Expenses — — — — —
D&A 912,000.0 1.04 M 1.10 M — —
Interest Expense — — — — —
Income Tax — 45.99 M 59.99 M — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 10.79 M 18.71 M 34.13 M 37.77 M 51.22 M
Total Liabilities 4.70 M 5.25 M 5.79 M 5.49 M 6.10 M
Shareholders' Equity 6.08 M 13.47 M 28.34 M 32.28 M 45.12 M
Total Debt — — — 321,000.0 249,000.0
Cash & Equivalents 5.59 M 11.91 M 26.67 M 29.65 M 13.15 M
Current Assets 6.75 M 13.18 M 28.02 M 31.66 M 45.09 M
Current Liabilities 2.67 M 2.97 M 3.25 M 3.11 M 3.01 M